SCHEMBL18864232

SCHEMBL18864232

COCCN(CCOC)C(=O)c1cc(C(=O)O)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.53
KDM5B Q9UGL1 5/20 0.53
ALKBH5 Q6P6C2 4/20 0.53
KDM4C Q9H3R0 4/20 0.53
KDM5A P29375 4/20 0.53
KDM5C P41229 3/20 0.53
KDM4E B2RXH2 2/20 0.53
KDM6B O15054 2/20 0.53
KDM2A Q9Y2K7 2/20 0.53
KDM3A Q9Y4C1 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPT P10636 2/20 0.53
KDM4A O75164 2/20 0.53
TET3 O43151 1/20 0.53
BBOX1 O75936 1/20 0.53
ASPH Q12797 1/20 0.53
KDM4D Q6B0I6 1/20 0.53
TET2 Q6N021 1/20 0.53
KDM7A Q6ZMT4 1/20 0.53
KDM8 Q8N371 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18864231 0.92 MAPT (0.46) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL9730848 0.88 ALDH1A1 (0.43) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL3854386 0.84 KDM5B (0.57) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL5808530 0.81 ALDH1A1 (0.65) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL6990109 0.80 LPAR1 (0.53) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL9731016 0.78 HCAR2 (0.40) KDM4EALDH1A1MLYCDSCN9A
SCHEMBL6993029 0.78 ALDH1A1 (0.48) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL6239722 0.77 KDM5B (0.49) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL6985928 0.77 KDM5B (0.49) FTOKDM5BALKBH5KDM4CKDM5A
SCHEMBL9731029 0.77 SCN9A (0.41) KDM4EALDH1A1MAPTL3MBTL1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240307477-A1 COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS INCLUDING SANGUISORBA OFFICINALIS EXTRACT AS ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-09-19 US disclosed
WO-2023063663-A1 COMPOSITION FOR PREVENTING OR TREATING HEPATIC FIBROSIS, COMPRISING BETA-GUANIDINOPROPIONIC ACID 주식회사 휴엔켐 2023-04-20 WO disclosed
US-9895370-B2 Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient PHARMEDIX.CO., LTD (KR) 2018-02-20 US disclosed
US-20170143714-A1 Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2017-05-25 US disclosed